{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:00:34Z","timestamp":1782741634729,"version":"3.54.5"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health","award":["5P20GM109025"],"award-info":[{"award-number":["5P20GM109025"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.neuropharm.2018.04.021","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T23:17:34Z","timestamp":1525562254000},"page":"164-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer's disease and vascular dementia"],"prefix":"10.1016","volume":"137","author":[{"given":"Andrew S.","family":"Murtishaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelcie F.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal Courtney D.","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Langhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson W.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuropharm.2009.01.005","article-title":"A\u00a0study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia","volume":"56","author":"Agrawal","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.neuropharm.2018.04.021_bib3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archneur.63.11.1551","article-title":"Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study","volume":"63","author":"Akomolafe","year":"2006","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med. J. British Diab. Assoc."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib5","first-page":"569","article-title":"Dementia and insulin resistance in patients with diabetes mellitus","volume":"68","author":"Araki","year":"2010","journal-title":"Nihon Rinsho. Jpn. J. Clin. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.04.021_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jnen\/61.6.557","article-title":"Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles","volume":"61","author":"Augustinack","year":"2002","journal-title":"JNEN (J. Neuropathol. Exp. Neurol.)"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0006-8993(85)90730-9","article-title":"An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat","volume":"331","author":"Bai","year":"1985","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-2012-121030","article-title":"Increased tau phosphorylation and impaired insulin\/IGF signaling in mice fed a high fat\/high cholesterol diet","volume":"36","author":"Bhat","year":"2013","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7257\/1053-816X.2016.36.1.27","article-title":"Diabetes mellitus review","volume":"36","author":"Blair","year":"2016","journal-title":"Urol. Nurs."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.04.021_bib12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.04.021_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ahj.2005.04.027","article-title":"Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance","volume":"150","author":"Carmena","year":"2005","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/dmrr.634","article-title":"Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases","volume":"22","author":"Cersosimo","year":"2006","journal-title":"Diabetes Metabol. Res. Rev."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.04.021_bib16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.neurobiolaging.2006.06.007","article-title":"The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old","volume":"28","author":"Chinnici","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.neuropharm.2018.04.021_bib17","first-page":"950","article-title":"Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy","volume":"11","author":"Chopra","year":"2010","journal-title":"J.\u00a0Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.22234","article-title":"5-lipoxygenase as an endogenous modulator of amyloid \u03b2 formation in\u00a0vivo","volume":"69","author":"Chu","year":"2011","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.neurobiolaging.2012.12.009","article-title":"5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in\u00a0vivo: involvement of the cyclin-dependent kinase-5","volume":"34","author":"Chu","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neuropharm.2018.04.021_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","article-title":"Anatomy and regulation of the central melanocortin system","volume":"8","author":"Cone","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in alzheimer disease and vascular dementia","volume":"66","author":"Craft","year":"2009","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-4580(95)02002-0","article-title":"Memory improvement following induced hyperinsulinemia in Alzheimer's disease","volume":"17","author":"Craft","year":"1996","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"Crawley","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720507780362245","article-title":"Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease","volume":"4","author":"Deane","year":"2007","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/Amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1258\/la.2010.010090","article-title":"Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models","volume":"45","author":"Deeds","year":"2011","journal-title":"Lab. Anim"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2251-6581-12-60","article-title":"Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans","volume":"12","author":"Eleazu","year":"2013","journal-title":"J.\u00a0Diabetes Metab. Disord."},{"issue":"12","key":"10.1016\/j.neuropharm.2018.04.021_bib29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s001250051564","article-title":"Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin","volume":"43","author":"Elsner","year":"2000","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/187153012800493477","article-title":"Cerebrovascular complications of diabetes: focus on stroke","volume":"12","author":"Ergul","year":"2012","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib31","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in\u00a0vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib32","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2018.04.021_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fimmu.2015.00515","article-title":"Leukotriene B4 as a potential therapeutic target for the treatment of metabolic disorders","volume":"6","author":"Filgueiras","year":"2015","journal-title":"Front. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2018.04.021_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"J.\u00a0Neural. Transm."},{"issue":"12","key":"10.1016\/j.neuropharm.2018.04.021_bib35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0006-3223(91)90158-I","article-title":"Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type","volume":"30","author":"Fujisawa","year":"1991","journal-title":"Biol. Psychiatr."},{"issue":"C","key":"10.1016\/j.neuropharm.2018.04.021_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2013.04.052","article-title":"Cerebral amyloidal angiopathy\u2014a disease with implications for neurology and psychiatry","volume":"1519","author":"Gahr","year":"2013","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2018.04.021_bib37","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained Interleukin-1 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib38","first-page":"1433","article-title":"Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in\u00a0vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose","volume":"130","author":"Giorgino","year":"1992","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.neuropharm.2018.04.021_bib39","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib40","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1152\/ajprenal.00204.2005","article-title":"Impact of genetic background on nephropathy in diabetic mice","volume":"290","author":"Gurley","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1089\/jmf.2009.1242","article-title":"Water extract of Triticum aestivumL. And its components demonstrate protective effect in a model of vascular dementia","volume":"13","author":"Han","year":"2010","journal-title":"J.\u00a0Med. Food"},{"issue":"5580","key":"10.1016\/j.neuropharm.2018.04.021_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.04.021_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbi.2014.01.019","article-title":"Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness","volume":"213","author":"Hassan","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2018.04.021_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2015.06.022","article-title":"Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory","volume":"50","author":"Heisler","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","article-title":"Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility","volume":"11","author":"Hill","year":"2010","journal-title":"Cell Metabol."},{"issue":"6\u20137","key":"10.1016\/j.neuropharm.2018.04.021_bib46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2009.03.001","article-title":"Downregulation of LPR1 at the blood-brain barrier in streptozotocin-induced diabetic mice","volume":"56","author":"Hong","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2018.04.021_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2018.04.021_bib48","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1369\/jhc.2008.951855","article-title":"Increased 5-lipoxygenase immunoreactivity in the Hippocampus of patients with Alzheimer's disease","volume":"56","author":"Ikonomovic","year":"2008","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2018.04.021_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2013.00017","article-title":"Pathology and pathogenesis of vascular cognitive impairment-a critical update","volume":"5","author":"Jellinger","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.04.021_bib50","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neurobiolaging.2013.11.016","article-title":"Modulation of lipopolysaccharide-induced memory insult, \u03b3-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase","volume":"35","author":"Joshi","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"22","key":"10.1016\/j.neuropharm.2018.04.021_bib51","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1016\/S0021-9258(18)89879-9","article-title":"Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats","volume":"259","author":"Kadowaki","year":"1984","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.04.021_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(02)00256-3","article-title":"Similarities between Alzheimer's disease and vascular dementia","volume":"203\u2013204","author":"Kalaria","year":"2002","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.04.021_bib53","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/STROKEAHA.112.655803","article-title":"Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans","volume":"43","author":"Kalaria","year":"2012","journal-title":"Stroke J. Cerebral Circ."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuropharm.2018.04.021_bib54","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of alzheimer disease and vascular dementia","volume":"13","author":"Kalaria","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.STR.0000258041.75739.cb","article-title":"Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia\/reperfusion in rats: relation to blood-brain barrier dysfunction","volume":"38","author":"Kamada","year":"2007","journal-title":"Stroke J. Cerebral Circ."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib56","first-page":"118","article-title":"ApoE genotypes: risk factor for Alzheimer's disease","volume":"7","author":"Kapur","year":"2006","journal-title":"J.\u00a0Indian Acad. Clin. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.56.1.42","article-title":"Cardiovascular risk factors and cognitive decline in middle-aged adults","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.04.021_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jns.2012.03.027","article-title":"Journal of the neurological Sciences","volume":"322","author":"Korczyn","year":"2012","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"5259","key":"10.1016\/j.neuropharm.2018.04.021_bib59","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-005-0069-1","article-title":"Diabetes and brain aging: epidemiologic evidence","volume":"5","author":"Launer","year":"2005","journal-title":"Curr. Diabetes Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BST0360343","article-title":"Oxidative stress: the vulnerable beta-cell","volume":"36","author":"Lenzen","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2018.04.021_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbi.2012.12.003","article-title":"Insulin-degrading enzyme deficiency accelerates cerebrovascular amyloidosis in an animal model","volume":"30","author":"Lifshitz","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2006.09.061","article-title":"Impaired function and expression of P-glycoprotein in blood\u2013brain barrier of streptozotocin-induced diabetic rats","volume":"1123","author":"Liu","year":"2006","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2018.04.021_bib64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1369\/0022155414546692","article-title":"Comparative analysis of H&E and Prussian blue staining in a mouse model of cerebral microbleeds","volume":"62","author":"Liu","year":"2014","journal-title":"J.\u00a0Histochem. Cytochem. Offic. J. Histochem. Soc."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0041-1345(97)01425-5","article-title":"Effects of high or low dose of streptozocin on pancreatic islets in C57BL\/6 and C.B17-SCID mice","volume":"30","author":"Lu","year":"1998","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.neuropharm.2018.04.021_bib66","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1124\/dmd.107.015800","article-title":"Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: evidence for the involvement of nuclear factor-kappaB, a nitrosative stress-sensitive transcription factor, in the regulation","volume":"35","author":"Maeng","year":"2007","journal-title":"Drug Metabol. Dispos. Biolog. Fate Chem."},{"issue":"14","key":"10.1016\/j.neuropharm.2018.04.021_bib67","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2018.04.021_bib68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuropharm.2015.08.044","article-title":"Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats","volume":"101","author":"Murtishaw","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib69","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<176::AID-PATH433>3.0.CO;2-8","article-title":"Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model","volume":"178","author":"O'Brien","year":"1996","journal-title":"J.\u00a0Pathol."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib70","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10072-014-1628-5","article-title":"Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats","volume":"35","author":"Ola","year":"2014","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib71","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbadis.2011.03.008","article-title":"Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2\u2013Keap1 signaling","volume":"1812","author":"Palsamy","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib72","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains","volume":"25","author":"P\u00e9rez","year":"2000","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib74","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2018.04.021_bib75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.brainres.2011.01.084","article-title":"Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain","volume":"1383","author":"Qu","year":"2011","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2018.04.021_bib76","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-5728(03)00037-7","article-title":"Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease","volume":"137","author":"Quinn","year":"2003","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"10","key":"10.1016\/j.neuropharm.2018.04.021_bib77","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1167\/iovs.09-5144","article-title":"Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR)","volume":"51","author":"Rao","year":"2010","journal-title":"Invest. Opthalmol. Visual Sci."},{"issue":"11","key":"10.1016\/j.neuropharm.2018.04.021_bib78","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1053\/meta.2000.17721","article-title":"A\u00a0new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat","volume":"49","author":"Reed","year":"2000","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/diacare.19.6.587","article-title":"Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly: the honolulu heart program","volume":"19","author":"Rodriguez","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2018.04.021_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2013.06.040","article-title":"Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats","volume":"550","author":"Sabbagh","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.04.021_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuropharm.2012.09.015","article-title":"Ciliary neurotrophic factor activates NF-\u03baB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents","volume":"65","author":"Saleh","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib82","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-2009-1184","article-title":"Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta","volume":"18","author":"Salkovic-Petrisic","year":"2009","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/STROKEAHA.111.637389","article-title":"Perioperative stroke: time to redefine the impact of age?","volume":"43","author":"Sanders","year":"2012","journal-title":"Stroke J. Cerebral Circ."},{"issue":"8","key":"10.1016\/j.neuropharm.2018.04.021_bib84","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.neuropharm.2018.04.021_bib85","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"\u03b2-amyloid, blood vessels, and brain function","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke J. Cerebral Circ."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib86","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2018.04.021_bib87","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nn1550","article-title":"Topographic mapping of VMH \u2192 arcuate nucleus microcircuits and their reorganization by fasting","volume":"8","author":"Sternson","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib88","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib89","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2018.04.021_bib90","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1074\/jbc.M112.393108","article-title":"Insulin-degrading enzyme (IDE): a novel heat shock-like protein","volume":"288","author":"Tundo","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.04.021_bib91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer's disease","volume":"37","author":"Tuppo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12640-009-9000-x","article-title":"Consumption of grape seed extract prevents amyloid-\u03b2 deposition and attenuates inflammation in brain of an Alzheimer's disease mouse","volume":"15","author":"Wang","year":"2009","journal-title":"Neurotox. Res."},{"issue":"46","key":"10.1016\/j.neuropharm.2018.04.021_bib93","article-title":"Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model","volume":"5","author":"Wang","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.neuropharm.2018.04.021_bib94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00207454.2013.866110","article-title":"Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs\/RAGE\/NF-\u03baB pathway","volume":"124","author":"Wang","year":"2013","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2018.04.021_bib95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","article-title":"Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage","volume":"1","author":"Wilcock","year":"2004","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"5","key":"10.1016\/j.neuropharm.2018.04.021_bib96","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1460-9568.2004.03214.x","article-title":"Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor","volume":"19","author":"Wrenn","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2018.04.021_bib97","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2018.04.021_bib98","first-page":"371","article-title":"Cerebral amyloid angiopathy in the aged","volume":"234","author":"Yamada","year":"1987","journal-title":"J.\u00a0Neurol."},{"issue":"6593","key":"10.1016\/j.neuropharm.2018.04.021_bib99","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuropharm.2018.04.021_bib100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0404.2007.00928.x","article-title":"Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats","volume":"117","author":"Zhang","year":"2008","journal-title":"Acta Neurol. Scand."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2018.04.021_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2004.02.045","article-title":"Insulin and the insulin receptor in experimental models of learning and memory","volume":"490","author":"Zhao","year":"2004","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T07:09:48Z","timestamp":1751612988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081830176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":101,"alternative-id":["S002839081830176X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.04.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer's disease and vascular dementia","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}